Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo-Han Kim

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
The Korean Journal of Internal Medicine|May 22, 2015
Reference interval for thyrotropin in a ultrasonography screened Korean populationMijin Kim, Tae Yong Kim, Soo Han Kim, et al.
Korean Circulation Journal|May 20, 2024
Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster RegistrySoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Anticancer Research|September 30, 2024
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLCInsu Kim, Sun Ha Choi, Shin Yup Lee, et al.
Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
The Korean Journal of Internal Medicine|May 22, 2015
Reference interval for thyrotropin in a ultrasonography screened Korean populationMijin Kim, Tae Yong Kim, Soo Han Kim, et al.
Korean Circulation Journal|May 20, 2024
Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster RegistrySoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Anticancer Research|September 30, 2024
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLCInsu Kim, Sun Ha Choi, Shin Yup Lee, et al.
Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.
Pageof 15